Alpha-hydroxybutyrate dehydrogenase as a biomarker for predicting systemic lupus erythematosus with liver injury.

CONCLUSION: α-HBDH could be used to evaluate the disease activity of SLE-related liver injury, and it may be a potential biomarker for diagnosing SLE-related liver injury.
PMID: 31669891 [PubMed - as supplied by publisher]

Source: International Immunopharmacology - October 23, 2019 Category: Allergy & Immunology Authors: Yu H, Han H, Li J, Li D, Jiang L Tags: Int Immunopharmacol Source Type: research